|Bid||559.41 x 1000|
|Ask||561.04 x 900|
|Day's Range||554.09 - 562.70|
|52 Week Range||309.38 - 573.79|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||8.72|
|Earnings Date||Oct 29, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||603.75|
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the third quarter 2020 on Thursday, October 29, 2020, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.
'You have to put all your money into 5 stocks and hold it for 10 years, what are you buying and why?'
Bio-Rad (BIO) is optimistic about maintaining robust testing portfolio along with strength in its Life Sciences business.